LysoPC(22:4)
|
Basic information |
| Metabolite name | LysoPC(22:4) |
 | N/A |
 |
C04230 |
 |
N/A |
| Synonyms | NA |
| No. of studies | 4 |
|
Basic information |
| Metabolite name | LysoPC(22:4) |
| N/A |
|
C04230 |
|
N/A |
| Synonyms | NA |
| No. of studies | 4 |
|
Relationship between LysoPC(22:4) and depression (count: 4) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M061 | Type1 | depressed group vs. control group | Plasma | Human | Up |
| Study M1117 | Type1 | MDD group vs. control group, Chinese cohort | Plasma | Human | Up |
| Study M898 | Type1 | end-stage renal disease with depression group vs. end-stage renal disease without depression group | Serum | Human | Up |
| Study M972 | Type1 | CRS + irradiation group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M972 | Type2 | CRS + irradiation + Paeoniae Radix Alba group vs. CRS + irradiation group | Serum | Sprague-Dawley rat | Up |
| Study M972 | Type2 | CRS + irradiation + albiflorin group vs. CRS + irradiation group | Serum | Sprague-Dawley rat | Up |
| Study M972 | Type2 | CRS + irradiation + paeoniflorin group vs. CRS + irradiation group | Serum | Sprague-Dawley rat | Up |